Effect of Laris - Hyssop combined herbal distilled on the improving clinical and paraclinical symptoms in patients with COVID-19
- Conditions
- COVID-19.Novel Cronavirus Disease (COVID-19)U07.01
- Registration Number
- IRCT20200518047497N1
- Lead Sponsor
- Tabriz University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 80
COVID-19 patients aged 15 years and older
Newly admitted people (first day of hospitalization)
Obtaining informed consent to participate in the trial
Non-participation in another clinical trial simultaneously
Epilepsy
Having liver or kidney failure according to the patient's statement, and doctor examination or based on creatinine, SGOT, SGPT, LDH tests.
Having a chronic disease (cardiovascular disease, uncontrolled high blood pressure (hypertension above 160/100 despite taking medication), complicating diabetes, respiratory diseases, BMI> 40 according to the patient's statement, and doctor examination
Immunodeficiency (treated with Corticosteroids over 12.5 mg / d Prednisolone for more than two weeks, chemotherapy, malignancies, organ transplants, HIV patients, other viral diseases)
Pregnancy (according to the patient's statement and examination by a doctor)
Breastfeeding (according to the patient's statement)
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Serum CRP level. Timepoint: Before-After intervention (14 days). Method of measurement: Biochemical method.;Number of inpatient days. Timepoint: After intervention. Method of measurement: Questionnaire.;Mortality. Timepoint: Daily. Method of measurement: Questionnaire.;Respiratory Rate. Timepoint: Daily. Method of measurement: Observation.;Oxygen saturation (SpO2). Timepoint: Daily. Method of measurement: Pulse Oximeter.;Serum White Blood Cell count. Timepoint: Before- After intervention (14 days). Method of measurement: laboratory cell counter.
- Secondary Outcome Measures
Name Time Method The time of absence of dry Cough. Timepoint: Daily. Method of measurement: Daily symptom questionnaire.;The time of absence of trembling. Timepoint: Daily. Method of measurement: Daily symptom questionnaire.;The time of absence of sore throat. Timepoint: Daily. Method of measurement: Daily symptom questionnaire.;The time of absence of difficulty breathing or shortness of breath. Timepoint: Daily. Method of measurement: Daily symptom questionnaire.;The time of absence of temperature equal to or grater than 37/8 C. Timepoint: Daily. Method of measurement: Daily symptom questionnaire.;Body temperature. Timepoint: Daily. Method of measurement: Thermometer.;Negative unilateral infiltration. Timepoint: After intervention. Method of measurement: Radiography- CT SCAN.;Negative bilateral infiltration. Timepoint: After intervention. Method of measurement: Radiography- CT SCAN.